Aurobindo Pharma said it’s wholly-owned subsidiary has entered into an agreement to acquire a product under development and related assets from Australia-based
Ms. Olivia Lam, Executive Director at Cedrus Investments ("Cedrus"), was one of the three keynote speakers at the "Australia Biotech Invest" held in Melbourne on 24th October 2017.